Elevated sodium levels in tumors boost T-cell metabolic fitness and cytotoxicity, revealing potential avenues for improving cancer therapies.

Researchers from Monash University, led by Associate Professor Mikaël Martino from the university’s Australian Regenerative Medical Research...

Learn why the FDA has mandated boxed warnings for CAR T-cell therapies, highlighting the risks of secondary malignancies.

Learn about how monoclonal B-cell lymphocytosis is linked to an elevated risk of skin cancer and other cancers.

Learn about how monoclonal B-cell lymphocytosis is linked to an elevated risk of skin cancer and other cancers.

Acepodia, a clinical─stage biotechnology company developing first─in─class cell therapies with its unique antibody─cell conjugation (ACC) and...

Acepodia, a clinical─stage biotechnology company developing first─in─class cell therapies with its unique antibody─cell conjugation (ACC) and...

TC BioPharm (Holdings) PLC (TC BioPharm), a clinical stage biotechnology company developing platform allogeneic gamma─delta T cell therapies for...

Mayo Clinic researchers mined the molecular foundations of cancer and uncovered a new reason chimeric antigen receptor (CAR-T cell therapy) fails in...

In a study using human breast cancer cells, scientists say they have potentially identified immune system white blood cells that appear to be the...